Filter News
Area of Research
News Topics
- (-) Biomedical (3)
- (-) Isotopes (2)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (1)
- Bioenergy (1)
- Biology (1)
- Chemical Sciences (3)
- Composites (2)
- Computer Science (3)
- Coronavirus (2)
- Fusion (1)
- Materials (7)
- Materials Science (9)
- Microscopy (2)
- Molten Salt (2)
- Nanotechnology (4)
- National Security (1)
- Neutron Science (14)
- Nuclear Energy (3)
- Physics (2)
- Polymers (3)
- Quantum Science (2)
- Sustainable Energy (2)
- Transportation (1)
Media Contacts
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
Researchers from NASA’s Jet Propulsion Laboratory and Oak Ridge National Laboratory successfully created amorphous ice, similar to ice in interstellar space and on icy worlds in our solar system. They documented that its disordered atomic behavior is unlike any ice on Earth.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.